We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

Share Price Information for Marlowe (MRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 505.00
Bid: 504.00
Ask: 506.00
Change: 1.00 (0.20%)
Spread: 2.00 (0.397%)
Open: 508.00
High: 508.00
Low: 505.00
Prev. Close: 504.00
MRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of the Placing

26 Jun 2020 14:39

RNS Number : 2663R
Marlowe PLC
26 June 2020
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT (THE "ANNOUNCEMENT") IS DEEMED BY THE GROUP TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

26 June 2020

 

Marlowe plc

 

Results of the Placing

 

Further to the announcement of 26 June 2020 of the acquisition of Elogbooks and the proposed placing to raise a minimum of £35 million (the "Placing Announcement"), Marlowe plc ("Marlowe" or the "Group"), the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that, following significant investor demand, it has successfully raised £40 million before expenses under the Placing. The Placing Price of 478 pence per share represents a nil discount to the closing price on 25 June 2020.

 

Definitions

Other than where defined, capitalised terms used in this announcement have the meanings given to them in the Placing Announcement.

 

Results of the Placing

Pursuant to the Placing Announcement, the Group is pleased to announce that a total of 8,368,200 Placing Shares have been successfully placed at a price of 478 pence per Ordinary Share, with institutional investors. The Placing was significantly oversubscribed. Pursuant to the Placing, the Group has raised gross proceeds of £40 million (net proceeds of approximately £39 million after expenses).

 

A total of 4,410,430 Ordinary Shares have been placed pursuant to the First Placing and a total of 3,957,770 Ordinary Shares have been placed pursuant to the Second Placing. The issue of the Second Placing Shares remains subject to, inter alia, the granting by Shareholders of authorities to the Directors to dis-apply the pre-emption rights contained within the Articles and to issue the Second Placing Shares.

 

Cenkos and Berenberg acted as lead bookrunners in connection with the Placing, and Stifel acted as bookrunner.

 

General Meeting

A General Meeting to consider and approve the Second Placing will be held at 20 Grosvenor Place, London SW1X 7HN at 11.00 a.m. on 15 July 2020. A circular convening the General Meeting is expected to be posted to Shareholders on 29 June 2020 and will be made available on the Group's website at www.marloweplc.com.

 

Recommendation and voting intentions

The Directors believe the Second Placing to be in the best interests of the Group and its Shareholders as a whole. Accordingly, the Directors unanimously recommend Shareholders to vote in favour of the Resolutions as they intend so to do in respect of their beneficial shareholdings.

 

Other than where defined, capitalised terms used in this announcement have the meanings given to them in the Placing Announcement.

 

 

Expected Timetable of Principal Events

2020

Announcement of the Acquisition and Placing

7.00 a.m. on 26 June

Latest time for announcement of the results of the Placing

3.00 p.m. on 26 June

Posting of the Circular and Form of Proxy

29 June

First Admission and commencement of dealings of the First Placing Shares

8.00 a.m. on 30 June

First Placing Shares credited to CREST stock accounts

30 June

Despatch of definitive share certificates for First Placing Shares

week commencing 6 July

Latest time and date for receipt of Forms of Proxy

11.00 a.m. on 13 July

General Meeting

11.00 a.m. on 15 July

Second Admission and commencement of dealings of the Second Placing Shares if the Resolutions being passed

8.00 a.m. on 17 July

Second Placing Shares credited to CREST stock accounts, subject to the Resolutions being passed

17 July

Despatch of definitive share certificates for Second Placing Shares, subject to the Resolutions being passed

week commencing 20 July

Notes:

(i) References to times are to London time (unless otherwise stated).

(ii) If any of the above times or dates should change, the revised times and/or dates will be notified by the Group via an announcement to an RIS.

(iii) The timing of the events in the above timetable are indicative only.

 

Total Voting Rights

Application has been made for the First Placing Shares to be admitted to trading on AIM, and it is expected that Admission will occur at 8.00 a.m. on or around 30 June 2020. Following Admission of the First Placing Shares, the Group's issued ordinary share capital will comprise 50,455,989 Ordinary Shares, none of which are held in treasury.

 

Therefore, following Admission of the First Placing Shares, the total number of Ordinary Shares with voting rights in the Group will be 50,455,989, which may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.

 

Application will be made for the Second Placing Shares to be admitted to trading on AIM following the General Meeting.

 

 

For further information:

 

Marlowe plc

www.marloweplc.com

Alex Dacre, Chief Executive

Tel: +44 (0) 203 841 6194

Mark Adams, Group Finance Director

IR@marloweplc.com

Cenkos Securities plc - Nominated Adviser, Joint Broker & Lead Bookrunner

Nicholas Wells

Tel: +44 (0)20 7397 8900

Ben Jeynes

Harry Hargreaves

Joh. Berenberg, Gossler & Co. KG, London Branch - Joint Broker & Lead Bookrunner

Mark Whitmore

Ben Wright

Tel: +44 (0)20 3207 7800

Yudith Karunaratna

Stifel Nicolaus Europe Limited - Bookrunner

Matthew Blawat Tel: +44 (0)20 7710 7600

Francis North

FTI Consulting

Nick Hasell

Tel: +44 (0)20 3727 1340

Alex Le May

 

 

About Marlowe plc

Marlowe is a UK leader in specialist services which assure the safety and regulatory compliance of commercial properties, whilst managing risk for businesses across the country. The Group was formed to create sustainable shareholder value through the acquisition and development of businesses that provide regulated inspection, testing and compliance services. It is focused on health & safety, fire safety, security, water safety, water treatment, air quality and environmental services - all of which are vital to the wellbeing of its customers operations and are invariably governed by regulation. Marlowe currently provides services to over 10% of Britain's commercial properties and is increasingly attractive to customers who require a single outsourced, nationwide, provider of a comprehensive range of regulated safety services. Our customers can be found in most office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

Cenkos and Stifel, each of which is authorised and regulated in the United Kingdom by the FCA, and Berenberg, which is authorised and regulated by the Federal Financial Supervisory Authority in Germany and subject to limited regulation in the UK by the Financial Conduct Authority, are acting for the Company and for no one else in connection with the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Cenkos, Stifel and Berenberg or for providing advice in relation to the Placing, or any other matters referred to in this Announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIFLFVVRRIRFII
Date   Source Headline
8th Apr 20242:54 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
26th Mar 20244:45 pmRNSBlock listing Interim Review
18th Mar 20247:00 amRNSBoard Changes; Update re: Returns of Capital
26th Feb 20247:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
22nd Feb 20247:00 amRNSDisposal and Directorate Change
15th Jan 202410:23 amRNSChange of Nominated Adviser and Joint Broker
30th Nov 20237:00 amRNSTotal Voting Rights
28th Nov 20237:00 amRNSInterim results for the six months to 30 Sept 2023
23rd Nov 20237:00 amRNSNotice of Interim Results
31st Oct 20234:30 pmRNSTotal Voting Rights
27th Sep 20235:18 pmRNSHolding(s) in Company
26th Sep 20233:23 pmRNSBlock Admission
13th Sep 20236:15 pmRNSResult of AGM
13th Sep 20237:00 amRNSAnnual General Meeting and Trading Update
4th Sep 20237:00 amRNSHolding(s) in Company
8th Aug 20237:00 amRNSExercise of Share Options and Total Voting Rights
7th Aug 20237:45 amRNSResponse to Speculation
4th Aug 20233:50 pmRNSHolding(s) in Company
3rd Aug 20235:25 pmRNSHolding(s) in Company
31st Jul 20233:30 pmRNSIssue of Equity and Total Voting Rights
26th Jul 20237:00 amRNSAcquisition of IMSM
18th Jul 202312:15 pmRNSCapital Reduction Effective
13th Jul 20232:00 pmRNSPublication of Notice of AGM and Annual Report
29th Jun 20237:00 amRNSPreliminary results
26th Jun 20237:00 amRNSNotice of Full Year Results
23rd Jun 20234:56 pmRNSHolding(s) in Company
19th Jun 202311:06 amRNSResult of General Meeting
5th Jun 20239:31 amRNSHolding(s) in Company
2nd Jun 20232:51 pmRNSPosting of Circular and Notice of General Meeting
2nd Jun 202312:36 pmRNSHolding(s) in Company
18th Apr 20231:45 pmRNSHolding(s) in Company
29th Mar 20237:00 amRNSCapital Markets Day Replay
28th Mar 20237:00 amRNSCapital Markets Day and Trading Update
7th Mar 20237:00 amRNSNotice of Capital Markets Event
28th Feb 20232:20 pmRNSHolding(s) in Company
26th Jan 20231:46 pmRNSHolding(s) in Company
5th Jan 20237:00 amRNSNotice of Capital Markets Event
2nd Dec 20229:00 amRNSNotice of Investor Presentation
1st Dec 202210:34 amRNSDirector/PDMR Shareholding
1st Dec 20229:00 amRNSDirector/PDMR Shareholding
24th Nov 20222:14 pmRNSDirector/PDMR Shareholding
24th Nov 20221:48 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSHalf-year Report
21st Nov 202212:54 pmRNSExercise of Share Options and Total Voting Rights
17th Nov 20227:00 amRNSNotice of Interim Results
2nd Nov 20225:08 pmRNSHolding(s) in Company
19th Oct 202210:40 amRNSExercise of Share Options and Total Voting Rights
14th Oct 20223:12 pmRNSHolding(s) in Company
11th Oct 20221:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.